White-label vs co-branded research for investment platforms.
Should an investment platform offer research white-label or co-branded?
Choose white-label when clients expect one brand across every view and you already sell research as your own. Choose co-branded when showing an independent research partner builds client trust, or when you are adding research for the first time. The research itself is the same in both models.
The problem today
- Brand decisions get made before the client experience is clear.
- White-label shifts responsibility for research quality onto the platform.
- Co-branded can feel like sending clients elsewhere if the experience is not embedded.
How Reuben AI helps
White-label. One brand everywhere. Best when research is already part of your product.
Co-branded. Your brand with "Powered by Reuben AI". Signals an independent research partner.
Same research. Coverage, currency and evidence are identical in both models.
Questions to settle first
- Do your clients expect a single brand across every screen?
- Who inside the platform owns research quality?
- Would naming an independent research partner build trust with your clients?
- Is research a paid tier, a free benefit, or part of an existing service?
How Reuben AI supports both
Reuben AI is offered co-branded by default and white-label as the premium option. In both, every finding links to its evidence and research stays current, so the branding choice is commercial rather than technical.
What you get
- Branding decision checklist
- Client experience outline
Security and trust
- Client data is isolated, with access control and an audit trail on every record.
- Data residency is available in APAC, EMEA or the Americas.
- Every finding is fully sourced and marked verified or cross-checked.
- People make the decisions. Reuben AI does not give investment advice.